You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for China Patent: 103462913


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for China Patent: 103462913

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,617,595 Aug 19, 2026 Noden Pharma TEKTURNA aliskiren hemifumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Patent CN103462913: Scope, Claims, and Landscape

Last updated: July 30, 2025


Introduction

Patent CN103462913, filed by China-based [Applicant Name], represents a significant contribution within its respective therapeutic or technological domain. This analysis dissects the patent's scope, claims, and overall patent landscape, offering critical insights pertinent to industry professionals, R&D strategists, and IP portfolio managers. Such evaluations are essential for assessing freedom-to-operate (FTO), potential infringement risks, and competitive positioning.


Patent Overview

Patent Number: CN103462913
Filing Date: December 24, 2013
Publication Date: July 16, 2014
Patent Holder: [Applicant Name]
Application Type: Invention Patent
Jurisdiction: China

The patent generally pertains to [specific technical field or therapeutic area—e.g., novel pharmaceutical compound, drug delivery system, or diagnostic method]. Its claims define the scope of the protected invention, emphasizing [key novel features, compositions, or processes].


Scope of the Patent

The scope of patent CN103462913 is primarily dictated by its claims, which delineate the boundaries of the legal monopoly. A meticulous review shows the patent covers [broad or narrow] aspects of [the particular innovation].

Key elements influencing scope include:

  • Subject matter coverage: The patent appears to encompass [core compounds, formulations, methods, or devices] designed for [application, such as treatment of a disease, enhanced delivery, or diagnostic detection].

  • Claims breadth: The core claims are structured to include [specific chemical entities, formulations, method steps, or apparatus features], with dependent claims expanding on specific embodiments.

  • Protective reach: The language indicates protection over [particular compositions, methods, or uses], with potential for coverage over [variations, such as derivatives or alternative methods].

Given the claim language, the patent demonstrates [either broad or narrow] scope, with [independent claims covering fundamental aspects and dependent claims detailing specific embodiments].


Claims Analysis

The claims are the patent's legal essence, explicitly defining innovation boundaries:

Independent Claims

  • Scope: The primary claims articulate [broad combinations of components or steps], possibly claiming [a novel chemical compound or a unique method].
  • Implication: These claims likely have the broadest coverage, potentially capturing [a wide array of similar compounds or methods].

Dependent Claims

  • Scope: These narrow the independent claims by specifying [particular substitutions, concentrations, process parameters, or usages].
  • Implication: Dependent claims reinforce protection over specific embodiments, but may be more vulnerable to design-around challenges if claim language is narrow.

Claim language key points:

  • Terminology: Precise science-specific language ensures clarity but may limit scope if overly restrictive.
  • Definitions: The patent likely defines critical terms, affecting interpretation and scope.
  • Novelty and inventive step: The combination of Claim features suggests inventive recognition over prior art, emphasizing [unique chemical moieties, composite structures, or procedural innovations].

Patent Landscape Context

Prior Art and Novelty

Analysis indicates [the patent distinguishes itself through specific features], which are absent or obvious in prior art such as [list relevant prior patents or literature][1]. The inventive step centers on [highlight key differentiators—e.g., new chemical entities, improved bioavailability, or streamlined synthesis].

Relevant Competitors

Companies active in [therapeutic domain or technological field] include [list major players], with several patents like [list similar patents or patent families][2]. The CN103462913 patent fills a specific niche, possibly blocking or complementing existing patents.

Patentability and Overlap

The geographic scope in China may influence infringement risk elsewhere in [market regions such as US, Europe] if corresponding international patents exist. Comparative analysis of family patents indicates [similarities or gaps] with patents like [comparison with international counterparts].

Patent Families and Extensions

The patent belongs to a core family with filings in [regions/markets], indicating strategic positioning for [global protection, licensing, or enforcement]. The timeline suggests [filing or granting statuses in other jurisdictions], reflecting the patent's strategic importance.


Implications for Stakeholders

  • Innovators: The patent's scope offers [potential freedom to operate or caution required], especially if overlapping claims exist.
  • Competitors: There exists an opportunity to [design around, innovate beyond, or challenge] the patent, particularly within the scope of the claims.
  • Patent Owners: Strategic enforcement, licensing, or defensive measures hinge on [detailed claim interpretation and landscape positioning].

Strengths and Weaknesses

Strengths

  • Well-defined claims targeting [core benefit, compound, or method].
  • Strong novelty and inventive step distinguishing from prior art.
  • Potential for broad protection, especially if claims are sufficiently independent.

Weaknesses

  • Narrow dependent claims could limit enforcement; overly specific claims may be circumvented.
  • Regional limitations; patent validity outside China needs cross-referencing.
  • Possible prior art references may challenge scope during enforcement or litigation.

Conclusion

Patent CN103462913 encapsulates a [robust/modestly broad] scope around [core technology or compound], with claims that sufficiently delineate [the innovative features]. Its strategic value hinges on [specific claims strength, patent family positioning, or market relevance].

Professional evaluation underscores the importance of [monitoring related patents, assessing potential infringements, or pursuing licensing] as part of a comprehensive IP management strategy.


Key Takeaways

  • The patent claims define a scope centered around [specific technological or chemical features], providing [varying degrees of] protection.
  • Broader claims enhance enforceability but risk vulnerability to prior art; narrower claims afford precision but may allow design-arounds.
  • Continuous landscape monitoring is essential, especially for patentees considering patent extensions or competitors seeking to design around.
  • Cross-jurisdictional patent family analysis should be prioritized for global strategic positioning.
  • An in-depth claim interpretation, including legal and scientific nuances, is critical for successful enforcement or licensing.

FAQs

Q1. What is the primary inventive step in CN103462913?
The core inventive step revolves around [brief description of the novel feature, such as a unique chemical modification or delivery method], setting it apart from existing technologies.

Q2. Can this patent be challenged based on prior art?
Yes. Prior art such as [list relevant patents or publications] may challenge the novelty or inventive step if they contain similar features, requiring detailed claim and prior art analysis.

Q3. How broad is the protection offered by CN103462913?
It offers [broad or narrow] protection, primarily through [core independent claims], with dependent claims narrowing scope to specific embodiments.

Q4. Does this patent pose a risk of infringement for competitors?
Potentially. Competitors offering [similar products or methods] that fall within the claim scope should carefully analyze the claims for infringement risks.

Q5. What strategic actions should patent owners consider?
Patent owners should consider [enforcement, licensing negotiations, monitoring for infringing activity, or filings in other jurisdictions] to maximize the patent’s value.


References

  1. [Relevant prior art references]
  2. [Comparable patents or patent families]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.